Use of resistance-area product derived from doppler MCA velocity to estimate the range of active cerebrovascular regulation

Michael L. Daley, Charles Leffler, S. Jackson, I. Piper

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The purpose of the present study was to explore the development of a method to estimate the range of active cerebrovascular regulation using resistance-area product (RAP) derived from transcranial Doppler ultrasound recordings of middle cerebral artery blood velocity (MCAV) obtained before and after physiologic challenge. Intracranial pressure (ICP), arterial blood pressure (ABP), and MCAV were monitored on 9 patients before and after challenges with either Noradrenlin or CO2 inhalation. One patient was monitored at 24, 48, 72, and 96 hrs. For each cardiac cycle a value of RAP was computed from the inverse of the slope of the regression line of paired values of aligned MCAV and ABP recordings. Mean values of percent change of difference of RAP (%ΔRAP) versus change of cerebral perfusion pressure (CPP) were computed. Theoretical values of %ΔRAP were derived from reported lab values of percent change diameter of arterioles versus ABP. Of the nine patients, 22% (2/9) demonstrated either impaired dilation and/or constriction. Furthermore, the correlation between theoretical and experimental values of %ΔRAP and CPP (n = 34) was strong (r =. 86, p <. 005). The serially-monitored patient failed to dilate during all CO2 challenges and to fully constrict to the Noradrenlin challenge at 72 hrs. %ΔRAP associated with corresponding changes of CPP may have value as a clinical method to estimate the range of active cerebrovascular regulation.

Original languageEnglish (US)
Pages (from-to)155-157
Number of pages3
JournalActa Neurochirurgica, Supplement
Volume81
StatePublished - Jan 1 2002

Fingerprint

Cerebrovascular Circulation
Middle Cerebral Artery
Arterial Pressure
Doppler Ultrasonography
Intracranial Pressure
Arterioles
Constriction
Inhalation
Dilatation

All Science Journal Classification (ASJC) codes

  • Surgery
  • Clinical Neurology

Cite this

Use of resistance-area product derived from doppler MCA velocity to estimate the range of active cerebrovascular regulation. / Daley, Michael L.; Leffler, Charles; Jackson, S.; Piper, I.

In: Acta Neurochirurgica, Supplement, Vol. 81, 01.01.2002, p. 155-157.

Research output: Contribution to journalArticle

@article{039eae2bfc54417ea251952f45cd9aeb,
title = "Use of resistance-area product derived from doppler MCA velocity to estimate the range of active cerebrovascular regulation",
abstract = "The purpose of the present study was to explore the development of a method to estimate the range of active cerebrovascular regulation using resistance-area product (RAP) derived from transcranial Doppler ultrasound recordings of middle cerebral artery blood velocity (MCAV) obtained before and after physiologic challenge. Intracranial pressure (ICP), arterial blood pressure (ABP), and MCAV were monitored on 9 patients before and after challenges with either Noradrenlin or CO2 inhalation. One patient was monitored at 24, 48, 72, and 96 hrs. For each cardiac cycle a value of RAP was computed from the inverse of the slope of the regression line of paired values of aligned MCAV and ABP recordings. Mean values of percent change of difference of RAP ({\%}ΔRAP) versus change of cerebral perfusion pressure (CPP) were computed. Theoretical values of {\%}ΔRAP were derived from reported lab values of percent change diameter of arterioles versus ABP. Of the nine patients, 22{\%} (2/9) demonstrated either impaired dilation and/or constriction. Furthermore, the correlation between theoretical and experimental values of {\%}ΔRAP and CPP (n = 34) was strong (r =. 86, p <. 005). The serially-monitored patient failed to dilate during all CO2 challenges and to fully constrict to the Noradrenlin challenge at 72 hrs. {\%}ΔRAP associated with corresponding changes of CPP may have value as a clinical method to estimate the range of active cerebrovascular regulation.",
author = "Daley, {Michael L.} and Charles Leffler and S. Jackson and I. Piper",
year = "2002",
month = "1",
day = "1",
language = "English (US)",
volume = "81",
pages = "155--157",
journal = "Acta Neurochirurgica, Supplement",
issn = "0065-1419",
publisher = "Springer Wien",

}

TY - JOUR

T1 - Use of resistance-area product derived from doppler MCA velocity to estimate the range of active cerebrovascular regulation

AU - Daley, Michael L.

AU - Leffler, Charles

AU - Jackson, S.

AU - Piper, I.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - The purpose of the present study was to explore the development of a method to estimate the range of active cerebrovascular regulation using resistance-area product (RAP) derived from transcranial Doppler ultrasound recordings of middle cerebral artery blood velocity (MCAV) obtained before and after physiologic challenge. Intracranial pressure (ICP), arterial blood pressure (ABP), and MCAV were monitored on 9 patients before and after challenges with either Noradrenlin or CO2 inhalation. One patient was monitored at 24, 48, 72, and 96 hrs. For each cardiac cycle a value of RAP was computed from the inverse of the slope of the regression line of paired values of aligned MCAV and ABP recordings. Mean values of percent change of difference of RAP (%ΔRAP) versus change of cerebral perfusion pressure (CPP) were computed. Theoretical values of %ΔRAP were derived from reported lab values of percent change diameter of arterioles versus ABP. Of the nine patients, 22% (2/9) demonstrated either impaired dilation and/or constriction. Furthermore, the correlation between theoretical and experimental values of %ΔRAP and CPP (n = 34) was strong (r =. 86, p <. 005). The serially-monitored patient failed to dilate during all CO2 challenges and to fully constrict to the Noradrenlin challenge at 72 hrs. %ΔRAP associated with corresponding changes of CPP may have value as a clinical method to estimate the range of active cerebrovascular regulation.

AB - The purpose of the present study was to explore the development of a method to estimate the range of active cerebrovascular regulation using resistance-area product (RAP) derived from transcranial Doppler ultrasound recordings of middle cerebral artery blood velocity (MCAV) obtained before and after physiologic challenge. Intracranial pressure (ICP), arterial blood pressure (ABP), and MCAV were monitored on 9 patients before and after challenges with either Noradrenlin or CO2 inhalation. One patient was monitored at 24, 48, 72, and 96 hrs. For each cardiac cycle a value of RAP was computed from the inverse of the slope of the regression line of paired values of aligned MCAV and ABP recordings. Mean values of percent change of difference of RAP (%ΔRAP) versus change of cerebral perfusion pressure (CPP) were computed. Theoretical values of %ΔRAP were derived from reported lab values of percent change diameter of arterioles versus ABP. Of the nine patients, 22% (2/9) demonstrated either impaired dilation and/or constriction. Furthermore, the correlation between theoretical and experimental values of %ΔRAP and CPP (n = 34) was strong (r =. 86, p <. 005). The serially-monitored patient failed to dilate during all CO2 challenges and to fully constrict to the Noradrenlin challenge at 72 hrs. %ΔRAP associated with corresponding changes of CPP may have value as a clinical method to estimate the range of active cerebrovascular regulation.

UR - http://www.scopus.com/inward/record.url?scp=0035989175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035989175&partnerID=8YFLogxK

M3 - Article

VL - 81

SP - 155

EP - 157

JO - Acta Neurochirurgica, Supplement

JF - Acta Neurochirurgica, Supplement

SN - 0065-1419

ER -